We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$260M
AUM Growth
+$22M
Cap. Flow
+$12.7M
Cap. Flow %
4.88%
Top 10 Hldgs %
34.67%
Holding
391
New
8
Increased
34
Reduced
90
Closed
22

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$943K
2
ADBE icon
Adobe
ADBE
+$778K
3
CELG
Celgene Corp
CELG
+$554K
4
BIIB icon
Biogen
BIIB
+$498K
5
IMO icon
Imperial Oil
IMO
+$400K

Sector Composition

Rank Sector Weight
1 Technology 17.95%
2 Miscellaneous 17.52%
3 Healthcare 15.33%
4 Consumer Staples 14.14%
5 Energy 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ES icon
151
Eversource Energy
ES
$26.7B
$57K 0.02%
951
LLY icon
152
Eli Lilly
LLY
$1.05T
$55K 0.02%
700
-100
-13% -$7.53K
MDT icon
153
Medtronic
MDT
$117B
$54K 0.02%
625
-701
-53% -$56.7K
SPY icon
154
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$54K 0.02%
260
STT icon
155
State Street
STT
$53.1B
$54K 0.02%
1,000
-60
-6% -$3.58K
FPO
156
DELISTED
First Potomac Realty Trust
FPO
$53K 0.02%
5,800
-4,900
-46% -$43.7K
ILMN icon
157
Illumina
ILMN
$32.6B
$49K 0.02%
360
ALL icon
158
Allstate
ALL
$65.9B
$48K 0.02%
685
IGSB icon
159
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$48K 0.02%
900
CTXS
160
DELISTED
Citrix Systems Inc
CTXS
$48K 0.02%
753
BSX icon
161
Boston Scientific
BSX
$67.9B
$47K 0.02%
2,000
CL icon
162
Colgate-Palmolive
CL
$72.3B
$45K 0.02%
610
-50
-8% -$3.56K
HSY icon
163
Hershey
HSY
$36B
$45K 0.02%
400
ACCO icon
164
Acco Brands
ACCO
$396M
$44K 0.02%
4,228
CMCSA icon
165
Comcast
CMCSA
$96B
$44K 0.02%
1,346
GWW icon
166
W.W. Grainger
GWW
$61.5B
$44K 0.02%
195
PBCT
167
DELISTED
People's United Financial Inc
PBCT
$44K 0.02%
3,000
D icon
168
Dominion Energy
D
$57.7B
$43K 0.02%
548
NSC icon
169
Norfolk Southern
NSC
$78.3B
$43K 0.02%
500
SWBI icon
170
Smith & Wesson
SWBI
$573M
$43K 0.02%
2,082
UTL icon
171
Unitil
UTL
$968M
$43K 0.02%
1,000
BABA icon
172
Alibaba
BABA
$296B
$42K 0.02%
525
DOC icon
173
Healthpeak Properties
DOC
$14.5B
$41K 0.02%
1,280
-110
-8% -$3.42K
MET icon
174
MetLife
MET
$61.3B
$40K 0.02%
1,122
ORCL icon
175
Oracle
ORCL
$435B
$40K 0.02%
982

Similar funds

American Research & Management Company's Q2 2016 Portfolio in Review

As of Q2 2016, American Research & Management Company held 391 positions worth $260M, up 9.3% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company deployed $12.7M of net new capital in Q2 2016, opening 8 new positions and adding to 34 existing holdings. Its largest new stake was Edwards Lifesciences: 3,900 shares worth $130K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was PRA Group, an estimated $738K trimmed.

  • American Research & Management Company's largest Q2 2016 buy was Edwards Lifesciences: 3,900 shares worth $130K.
  • American Research & Management Company added most to IBM in Q2 2016, an estimated $943K increase.
  • American Research & Management Company's biggest Q2 2016 reduction was PRA Group, cutting an estimated $738K.
  • American Research & Management Company fully exited RBS CAPITAL FUNDING TRUST VII GTD TR PFD SEC 6.08% in Q2 2016, selling an estimated $442K.
  • American Research & Management Company's ten largest holdings make up 35% of its $260M portfolio in Q2 2016.
  • American Research & Management Company opened 8 new positions and closed 22 in Q2 2016.
  • American Research & Management Company's portfolio value rose 9.3% quarter-over-quarter to $260M.

Based on American Research & Management Company's 13F filing for Q2 2016, filed 29 Jul 2016.